Clinical Insights Into Dextrose Phonophoresis on Mild to Moderate Acne Vulgaris
NCT ID: NCT07169890
Last Updated: 2025-12-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
115 participants
INTERVENTIONAL
2025-11-01
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris
NCT01773122
Combined Low-Dose Isotretenion and Long-Pulsed 1064 ND-YAG Laser in the Treatment of Acne Erythema
NCT05622253
Microneedling Plus the Universal Peel For Acne Scarring
NCT02174393
Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study
NCT00206895
A Study to Determine the Safety and Efficacy of an Ultrasound Device in the Management of Acute Acne Lesions
NCT01160757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The anti-inflammatory properties of dextrose are pivotal in its role in treating acne vulgaris. Acne is characterized by the inflammation of pilosebaceous units, and dextrose is believed to mitigate this inflammation through osmotic and possibly metabolic pathways. By reducing the inflammatory response, dextrose phonophoresis may decrease the erythema and lesion count associated with acne vulgaris.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dextrose Phonophoresis
An individually prepared and equivalent 4-g dose of 0.33% dexamethasone gel (Vann Healthcare Services Inc, Glasgow, KY) from the same lot was applied. A topical dexamethasone gel applied then ultrasound treatment
Dextrose Phonophoresis
To apply Dextrose Phonophoresis on a patient with acne vulgaris, begin by cleansing the affected skin area thoroughly with a gentle, non-comedogenic cleanser to remove any dirt or oils. Pat the skin dry with a clean towel. Prepare a dextrose gel, a 10% dextrose gel, which is then coupled with low-frequency ultrasound to facilitate deeper penetration of the dextrose
Ultrasound
Using an ultrasound device set to a frequency of 1 MHz, with an intensity ranging from 0.5 to 1.5 W/cm², the ultrasound probe is moved in a circular motion over the skin for a duration of 5 to 10 minutes per session.
Ultrasound
the ultrasound probe is moved in a circular motion over the skin for a duration of 5 to 10 minutes per session
Dextrose topical gel
Topical application of dextrose gel
Dextrose Topical application
Apply a thin layer of the dextrose gel evenly across the acne-affected areas using a sterile applicator or cotton pad
Control group
No intervention
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dextrose Phonophoresis
To apply Dextrose Phonophoresis on a patient with acne vulgaris, begin by cleansing the affected skin area thoroughly with a gentle, non-comedogenic cleanser to remove any dirt or oils. Pat the skin dry with a clean towel. Prepare a dextrose gel, a 10% dextrose gel, which is then coupled with low-frequency ultrasound to facilitate deeper penetration of the dextrose
Ultrasound
the ultrasound probe is moved in a circular motion over the skin for a duration of 5 to 10 minutes per session
Dextrose Topical application
Apply a thin layer of the dextrose gel evenly across the acne-affected areas using a sterile applicator or cotton pad
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Clinically diagnosed with mild to moderate acne vulgaris.
* Willingness to comply with the study protocol and attend all treatment sessions.
* Medical Clearance: Participants must have medical clearance to participate in this study.
Exclusion Criteria
* Current use of systemic acne medications or topical treatments other than the study intervention.
* Known allergy to magnesium or ultrasound gel.
* Pregnant or breastfeeding individuals.
* Severe Comorbidities: Individuals with severe cardiovascular, pulmonary, metabolic, or vascular diseases
* Medication Interference: Individuals using medications known to affect presence of acne.
* Acute Psychological Conditions: Participants with acute psychological conditions that may interfere with participation or assessments.
* Obese patient whose BMI ≥ 30.
18 Years
30 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
MTI University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mohamed Ahmed Abd El hady El Fahl,ph.d
Assisstant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
faculty of physical therapy ,Cairo University
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P.T.REC/012/005946
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.